Stellenbosch University homepage

ProfBienyameen Baker

Associate Professor

Molecular Biology And Human Genetics

Orcid identifier0000-0002-2158-6763
  • Associate Professor
    Molecular Biology And Human Genetics

RESEARCH INTERESTS

My current research focuses on the development of safe effective non-viral vectors to deliver a therapeutic gene/s. We aim to identify the target genes that can be employed in non-viral gene vectors for the treatment of tuberculosis, and will mainly focus on vectors to induce transgene expression of these target genes. Simple non-viral vector nanoparticles will be developed in collaboration with Prof Choonara and Prof Ely to transiently increase the expression of specific genes in combination and determine whether the growth of M.tb is inhibited, stimulated or unchanged in THP-1 cells. This data will be confirmed in human blood monocyte-derived macrophages. Animal TB infection models will be employed in collaboration with Prof. Jacobs and Prof Le Grand to assess the activity of the identified nanoparticles in-vivo. The most effective inhibition that results from the specific knock-up of a combination of one or more genes will be studied further in terms of toxicity to the host. If positive results are obtained at this stage, further funding will be applied for to perform a pilot human clinical trial to assess the efficacy of the designed nanoparticles in tuberculosis patients before a large scale clinical trial is feasible. In terms of the latter a collaboration with experts in the clinical trial arena will be forged to ensure a professional and timeous outcome. It is envisaged that simple vectors designed to knock-up genes transiently in combination with first-line drugs to promote M.tb destruction with little or no toxicity to the host may be developed further into safe and effective host-directed antitubercular therapies. Further, we are currently busy applying this technology to develop therapies for Cancer, Cardiovascular disease and viral infections.